{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T12:33:53Z","timestamp":1719405233681},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T00:00:00Z","timestamp":1703203200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T00:00:00Z","timestamp":1703203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1038\/s41440-023-01534-1","type":"journal-article","created":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T10:02:19Z","timestamp":1703239339000},"page":"1196-1207","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Automated electrochemiluminescence immunoassay for serum PlGF levels in women with singleton pregnancy at 9\u201313 weeks of gestation predicts preterm preeclampsia: a retrospective cohort study"],"prefix":"10.1038","volume":"47","author":[{"given":"Akihide","family":"Ohkuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayo","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikako","family":"Hirashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotada","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiho","family":"Nagayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Ogoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Horie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Usui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,22]]},"reference":[{"key":"1534_CR1","doi-asserted-by":"publisher","first-page":"e011801","DOI":"10.1136\/bmjopen-2016-011801","volume":"6","author":"N O\u2019Gorman","year":"2016","unstructured":"O\u2019Gorman N, Wright D, Rolnik DL, Nicolaides KH, Poon LC. Study protocol for the randomised controlled trial: combined multimarker screening and randomised patient treatment with ASpirin for evidence-based PREeclampsia prevention (ASPRE). BMJ Open. 2016;6:e011801.","journal-title":"BMJ Open"},{"key":"1534_CR2","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1056\/NEJMoa1704559","volume":"377","author":"DL Rolnik","year":"2017","unstructured":"Rolnik DL, Wright D, Poon LC, O\u2019Gorman N, Syngelaki A, de Paco Matallana C, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;377:613\u201322.","journal-title":"N Engl J Med"},{"key":"1534_CR3","first-page":"477","volume":"49","author":"CY Ong","year":"2004","unstructured":"Ong CY, Lao TT, Spencer K, Nicolaides KH. Maternal serum level of placental growth factor in diabetic pregnancies. J Reprod Med. 2004;49:477\u201380.","journal-title":"J Reprod Med"},{"key":"1534_CR4","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/uog.6244","volume":"32","author":"R Akolekar","year":"2008","unstructured":"Akolekar R, Zaragoza E, Poon LC, Pepes S, Nicolaides KH. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2008;32:732\u20139.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1534_CR5","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/pd.2496","volume":"30","author":"NJ Cowans","year":"2010","unstructured":"Cowans NJ, Stamatopoulou A, Spencer K. First trimester maternal serum placental growth factor in trisomy 21 pregnancies. Prenat Diagn. 2010;30:449\u201353.","journal-title":"Prenat Diagn"},{"key":"1534_CR6","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/uog.8890","volume":"37","author":"NJ Cowans","year":"2011","unstructured":"Cowans NJ, Stamatopoulou A, T\u00f8rring N, Spencer K. Early first-trimester maternal serum placental growth factor in trisomy 21 pregnancies. Ultrasound Obstet Gynecol. 2011;37:515\u20139.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1534_CR7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/uog.9029","volume":"38","author":"EJ Wortelboer","year":"2011","unstructured":"Wortelboer EJ, Koster MP, Kuc S, Eijkemans MJ, Bilardo CM, Schielen PC, et al. Longitudinal trends in fetoplacental biochemical markers, uterine artery pulsatility index and maternal blood pressure during the first trimester of pregnancy. Ultrasound Obstet Gynecol. 2011;38:383\u20138.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1534_CR8","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/pd.2807","volume":"31","author":"G Vandenberghe","year":"2011","unstructured":"Vandenberghe G, Mensink I, Twisk JW, Blankenstein MA, Heijboer AC, van Vugt JM. First trimester screening for intra-uterine growth restriction and early-onset pre-eclampsia. Prenat Diagn. 2011;31:955\u201361.","journal-title":"Prenat Diagn"},{"key":"1534_CR9","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/pd.4087","volume":"33","author":"K Donalson","year":"2013","unstructured":"Donalson K, Turner S, Morrison L, Liitti P, Nilsson C, Cuckle H. Maternal serum placental growth factor and \u03b1-fetoprotein testing in first trimester screening for Down syndrome. Prenat Diagn. 2013;33:457\u201361.","journal-title":"Prenat Diagn"},{"key":"1534_CR10","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/uog.14811","volume":"45","author":"A Tsiakkas","year":"2015","unstructured":"Tsiakkas A, Duvdevani N, Wright A, Wright D, Nicolaides KH. Serum placental growth factor in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol. 2015;45:591\u20138.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1534_CR11","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/pd.4597","volume":"35","author":"T Huang","year":"2015","unstructured":"Huang T, Dennis A, Meschino WS, Rashid S, Mak-Tam E, Cuckle H. First trimester screening for Down syndrome using nuchal translucency, maternal serum pregnancy-associated plasma protein A, free-\u03b2 human chorionic gonadotrophin, placental growth factor, and \u03b1-fetoprotein. Prenat Diagn. 2015;35:709\u201316.","journal-title":"Prenat Diagn"},{"key":"1534_CR12","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ejogrb.2016.03.046","volume":"201","author":"J Han","year":"2016","unstructured":"Han J, Liu H, Xu ZP, Cuckle H, Sahota D, Li DZ, et al. Maternal serum PlGF (placental growth factor) in Chinese women in the first trimester undergoing screening for Down syndrome. Eur J Obstet Gynecol Reprod Biol. 2016;201:166\u201370.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1534_CR13","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1093\/humrep\/dew225","volume":"31","author":"CN Jayasena","year":"2016","unstructured":"Jayasena CN, Abbara A, Comninos AN, Narayanaswamy S, Gonzalez Maffe J, Izzi-Engbeaya C, et al. Novel circulating placental markers prokineticin-1, soluble fms-like tyrosine kinase-1, soluble endoglin and placental growth factor and association with late miscarriage. Hum Reprod. 2016;31:2681\u20138.","journal-title":"Hum Reprod"},{"key":"1534_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000341264","volume":"33","author":"R Akolekar","year":"2013","unstructured":"Akolekar R, Syngelaki A, Poon L, Wright D, Nicolaides KH. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther. 2013;33:8\u201315.","journal-title":"Fetal Diagn Ther"},{"key":"1534_CR15","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1161\/HYPERTENSIONAHA.108.127977","volume":"53","author":"LC Poon","year":"2009","unstructured":"Poon LC, Kametas NA, Maiz N, Akolekar R, Nicolaides KH. First-trimester prediction of hypertensive disorders in pregnancy. Hypertension. 2009;53:812\u20138.","journal-title":"Hypertension"},{"key":"1534_CR16","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/uog.15816","volume":"47","author":"A Tsiakkas","year":"2016","unstructured":"Tsiakkas A, Cazacu R, Wright A, Wright D, Nicolaides KH. Maternal serum placental growth factor at 12, 22, 32 and 36 weeks\u2019 gestation in screening for pre-eclampsia. Ultrasound Obstet Gynecol. 2016;47:472\u20137.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1534_CR17","doi-asserted-by":"publisher","first-page":"650.e1","DOI":"10.1016\/j.ajog.2019.09.041","volume":"221","author":"P Chaemsaithong","year":"2019","unstructured":"Chaemsaithong P, Pooh RK, Zheng M, Ma R, Chaiyasit N, Tokunaka M, et al. Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population. Am J Obstet Gynecol. 2019;221:650.e1\u2013650.e16.","journal-title":"Am J Obstet Gynecol"},{"key":"1534_CR18","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/uog.22093","volume":"56","author":"A Mazer Zumaeta","year":"2020","unstructured":"Mazer Zumaeta A, Wright A, Syngelaki A, Maritsa VA, Da Silva AB, Nicolaides KH. Screening for pre-eclampsia at 11-13 weeks\u2019 gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both. Ultrasound Obstet Gynecol. 2020;56:400\u20137.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1534_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jogc.2020.06.011","volume":"43","author":"A Boutin","year":"2021","unstructured":"Boutin A, Gasse C, Guerby P, Gigu\u00e8re Y, T\u00e9tu A, Bujold E. First-trimester preterm preeclampsia screening in nulliparous women: the great obstetrical syndrome (GOS) Study. J Obstet Gynaecol Can. 2021;43:43\u20139.","journal-title":"J Obstet Gynaecol Can"},{"key":"1534_CR20","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.2147\/IJWH.S331213","volume":"13","author":"KS Law","year":"2021","unstructured":"Law KS, Wei TY. Effect of low-dose aspirin in preventing early-onset preeclampsia in the Taiwanese population-a retrospective cohort study. Int J Womens Health. 2021;13:1095\u2013101.","journal-title":"Int J Womens Health"},{"key":"1534_CR21","doi-asserted-by":"publisher","first-page":"161.e1","DOI":"10.1016\/j.ajog.2009.09.016","volume":"202","author":"S Verlohren","year":"2010","unstructured":"Verlohren S, Galindo A, Schlembach D, Zeisler H, Herraiz I, Moertl MG, et al. An automated method for the determination of the sFlt-1\/PIGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol. 2010;202:161.e1\u2013161.e11.","journal-title":"Am J Obstet Gynecol"},{"key":"1534_CR22","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/hr.2010.15","volume":"33","author":"A Ohkuchi","year":"2010","unstructured":"Ohkuchi A, Hirashima C, Suzuki H, Takahashi K, Yoshida M, Matsubara S, et al. Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia. Hypertens Res. 2010;33:422\u20137.","journal-title":"Hypertens Res"},{"key":"1534_CR23","unstructured":"https:\/\/www.info.pmda.go.jp\/downfiles\/ivd\/PDF\/700025_23100EZX00013000_A_04_02.pdf Elecsys sFlt-1\u00ae [package insert]. Accessed 2 March 2023."},{"key":"1534_CR24","unstructured":"https:\/\/www.info.pmda.go.jp\/downfiles\/ivd\/PDF\/700025_23100EZX00014000_B_02_02.pdf Elecsys PlGF\u00ae [package insert]. Accessed 2 March 2023."},{"key":"1534_CR25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/uog.21905","volume":"56","author":"P Chaemsaithong","year":"2020","unstructured":"Chaemsaithong P, Sahota D, Pooh RK, Zheng M, Ma R, Chaiyasit N, et al. First-trimester pre-eclampsia biomarker profiles in Asian population: multicenter cohort study. Ultrasound Obstet Gynecol. 2020;56:206\u201314.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1534_CR26","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41440-020-00571-4","volume":"44","author":"M Goto","year":"2021","unstructured":"Goto M, Koide K, Tokunaka M, Takita H, Hamada S, Nakamura M, et al. Accuracy of the FMF Bayes theorem-based model for predicting preeclampsia at 11-13 weeks of gestation in a Japanese population. Hypertens Res. 2021;44:685\u201391.","journal-title":"Hypertens Res"},{"key":"1534_CR27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.14390\/jsshp.HRP2018-014","volume":"6","author":"K Watanabe","year":"2018","unstructured":"Watanabe K, Matsubara K, Nakamoto O, Ushijima J, Ohkuchi A, Koide K, et al. Outline of the new definition and classification of \u201cHypertensive Disorders of Pregnancy (HDP)\u201d; a revised JSSHP statement of 2005. Hypertens Res Pregnancy. 2018;6:33\u20137.","journal-title":"Hypertens Res Pregnancy"},{"key":"1534_CR28","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1038\/s41440-022-01013-z","volume":"45","author":"A Ohkuchi","year":"2022","unstructured":"Ohkuchi A, Suzuki H, Matsubara K, Watanabe K, Saitou T, Oda H, et al. Exponential increase of the gestational-age-specific incidence of preeclampsia onset (COPE study): a multicenter retrospective cohort study in women with maternal check-ups at <20 weeks of gestation in Japan. Hypertens Res. 2022;45:1679\u201389.","journal-title":"Hypertens Res"},{"key":"1534_CR29","unstructured":"Confidence Interval Calculator. https:\/\/view.officeapps.live.com\/op\/view.aspx?src=https%3A%2F%2Fwww.pedro.org.au%2Fwp-content%2Fuploads%2FCIcalculator.xls&wdOrigin=BROWSELINK. Accessed 2 March 2023."},{"key":"1534_CR30","unstructured":"Risk assessment: Risk of preeclampsia. https:\/\/fetalmedicine.org\/research\/assess\/preeclampsia\/first-trimester. Accessed 2 March 2023."},{"key":"1534_CR31","doi-asserted-by":"publisher","first-page":"199.e1","DOI":"10.1016\/j.ajog.2018.11.1087","volume":"220","author":"D Wright","year":"2019","unstructured":"Wright D, Tan MY, O\u2019Gorman N, Poon LC, Syngelaki A, Wright A, et al. Predictive performance of the competing risk model in screening for preeclampsia. Am J Obstet Gynecol. 2019;220:199.e1\u2013199.e13.","journal-title":"Am J Obstet Gynecol"},{"key":"1534_CR32","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1111\/j.1600-0412.2012.01516.x","volume":"91","author":"LJ Vatten","year":"2012","unstructured":"Vatten LJ, \u00c5svold BO, Eskild A. Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction. Acta Obstet Gynecol Scand. 2012;91:1388\u201394.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"1534_CR33","doi-asserted-by":"publisher","first-page":"103.e1","DOI":"10.1016\/j.ajog.2015.08.034","volume":"214","author":"N O\u2019Gorman","year":"2016","unstructured":"O\u2019Gorman N, Wright D, Syngelaki A, Akolekar R, Wright A, Poon LC, et al. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation. Am J Obstet Gynecol. 2016;214:103.e1\u2013103.e12.","journal-title":"Am J Obstet Gynecol"},{"key":"1534_CR34","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/uog.17399","volume":"49","author":"N O\u2019Gorman","year":"2017","unstructured":"O\u2019Gorman N, Wright D, Poon LC, Rolnik DL, Syngelaki A, Wright A, et al. Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11\u201313 weeks\u2019 gestation. Ultrasound Obstet Gynecol. 2017;49:751\u20135.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1534_CR35","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/uog.19112","volume":"52","author":"MY Tan","year":"2018","unstructured":"Tan MY, Syngelaki A, Poon LC, Rolnik DL, O\u2019Gorman N, Delgado JL, et al. Screening for pre-eclampsia by maternal factors and biomarkers at 11\u201313\u2009weeks\u2019 gestation. Ultrasound Obstet Gynecol. 2018;52:186\u201395.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1534_CR36","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1038\/s41440-019-0307-6","volume":"42","author":"A Ohkuchi","year":"2019","unstructured":"Ohkuchi A, Hirashima C, Arai R, Takahashi K, Suzuki H, Ogoyama M, et al. Temporary hypertension and white coat hypertension in the first trimester as risk factors for preeclampsia. Hypertens Res. 2019;42:2002\u201312.","journal-title":"Hypertens Res"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01534-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01534-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01534-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T23:02:57Z","timestamp":1715036577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01534-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,22]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["1534"],"URL":"https:\/\/doi.org\/10.1038\/s41440-023-01534-1","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,22]]},"assertion":[{"value":"1 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}